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p P NGET H D PRAKTI OL H DOKTOR YANG MENGIKUTI 
DU PR KTI KLI IKAL (2009) KEMENTERIAN KESIHATAN 
T KRAW T DIABETE M LLITUS DIHOSPITALPULAU 
PI ANG. 
AB TRAK 
Literatur edia ada menyebut bahawa percanggahan pendapat antara doktor berkenaan syor 
berdasarkan garis panduan pengurusan diabetes melitus menjadi punca utama kurangnya 
kawalan diabetes melitus dalam kalangan pesakit. Kajian ini rnelibatkan 51 orang doktor yang 
terlibat dalam kajian ko-relasional yang dijalankan di Hospital Pulau Pinang (HPP). Matlamat 
kajian ialah untuk rnenilai pengetahuan. sikap doktor dan amalan penpreskripsian (diagnosis, 
penyaringan dan pengubatan) berdasarkan syor yang tertulis dalam Garis Panduan Amalan 
(Clinical Practice Guideline (CPG 2009) di Malaysia berkaitan dengan diabetes 
melitus serta faktor-faktor berkaitan pernatuban garis paduan dan kawalan diabetes rnelitus. 
Melalui kajian inL pengetabuan dan sikap dok.-tor ditaksir mengunakan borang soal selidik yang 
telab diperakui. Preskripsi yang ditulis oleb 51 orang doktor yang telab kenalpasti untuk 1020 
pesakit yang disabkan rnengidap diabetes (20 preskripsi bagi setiap doktor) berserta rnaklumat 
dernografi dan klinikal pesakit dicatat menggunakan 'peralatan pengumpulan data bervalidasi' 
(validated data collection tool). Preskripsi yang diperoleh diklasifikasikan sebagai komplians 
atau bukan kornplians dengan CPG 2009. Perisian SPSS versi 20 digunakan untuk menganalisis 
ilai p <0.05 dianggap sebagai signiftk:an secara statistik. Kajian mendapati babawa 
eramai 38 orang doktor (78%) mempunyai pengetahuan yang rnencukupi tentang garis panduan 
PG 2009. Kurnpulan yang terdiri daripada pakar perubatan mernpunyai pengetahuan yang lebih 
jika dibandingkan dengan pegawai perubatan atau pegawai perubatan pelatih (p-value <0.03). 
olongan doktor telah mernpamerkan sikap yang positif dan mesra terhadap syor garis panduan 
xvii i 
PG 2009 dengan skor min untuk sikap (atitud) bemilai 36.64 ± 3.93 mata dengan julat dari 35 
hingga 40 mata pada skala 50 mata. ecara statistik, korelasi yang kuat (nilai p <0.001) telah 
diperhatikan di antara pengetahuan yang ada pada doktor dan skor amalan (praktik). Serarnai 
tujuh ratus lima puluh orang pesakit (73.5%) telah menerima terapi yang komplian dengan garis 
panduan. ecara statistik, perkaitan positifyang sederhana signifikan (<I>= 0.591,p-value=0.001) 
telah diperoleh di antara diabetes melitus and kepatuhan terhadap CPG. Secara keseluruhan, 
tahap pengetahuan dan kepatuhan doktor serta kawalan dibetes melitus yang agak baik telah 
diarnati di Hospital Pulau Pinang. Jurang pemisah di antara syor garis panduan CPG 2009 dan 
arnalan telah diamati khususnya semasa penyaringan dan mendiagnosis komplikasi yang timbul 
akibat diabetes. Di samping itu, jurang pemisah juga diperhatikan dalam pengurusan diabetes 
melitus dan penyakit-penyakit renal. 
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V ALUATIO OF DOCTOR' KNOWLEDGE A D PRACTICE WITH REFERENCE 
TO CLI ICAL PRACTICE GUIDELI E (2009) MI ISTRY OF HEALTH MALAYSIA 
0 M GEME TOFDI BETE MELLITU ATHO PITALPULAUPI ANG. 
AB TRACT 
The available literature suggests that divergence of doctors with the recommendations of the 
guideline in the management of diabetes mellitus is the main reason for poor control of diabetes 
mellitus in patients. The current research in which 51 doctors were involved in the co-relational 
study conducted at Hospital Pulau Pinang (HPP). The aim was to evaluate the doctor's 
kno\\o ledge and prescription \\-Titing practices (diagnosis, screening and medication) on 
recommendations of Malaysian clinical practice guideline (CPG 2009) on diabetes mellitus, and 
factors concerning with the guideline adherence and diabetes mellitus control. Knowledge and 
attitude of doctors were evaluated by a validated questionnaire. Record of the patients written by 
51 enrolled doctors to 1020 established diabetic patients (20 Record of the patients per enrolled 
doctor) with demographic and clinical information of the patients were noted by validated data 
collection tool. The taken record of the patients was classified as compliance or noncompliance 
with CPG 2009. SPSS version 20 was used for data analysis. Ap-value <0.05 was considered as 
statistically significant. The total 38 (74.5%) doctors were having adequate knowledge on 
recommendations of CPG 2009. Group of specialists were having good knowledge as compared 
'\\oith medical officers and house officers (p-value <0.03). Doctors were having highly positive 
and welcoming attitude on recommendations of CPG 2009 with mean attitude score of 36.64 ± 
3.93 points ranging from 35-40 points on 50 point scale. Statistically strong association (p-
alue<O.OOl) was observed between doctors knowledge and practice score. Seven hundred and 
fifty (73.5%) patients were receiving guidelines compliance therapy. Statistically significant 
moderate positive association (<1>= 0.591, p-value=O.OOl) was observed between diabetes 
XX 
mellitu and PG adherence. An overall fair level of knowledge and adherence of doctors with 
fair control of diabetes mellitus was seen in HPP. The gap between recommendations of CPG 
2009 and practice was particularly ob erved in screening and diagnosis of diabetic 





The adherence of physician with guideline is directly affecting on the screening of disease and its 
complications and after that their treatments (Furthauer et a!., 2013). Generally, in qualitative 
and in quantitative studies the hurdles to guideline-adherence have been evaluated widely 
regarding the physician's point of view. There is need to evaluate the adherence of physicians 
with his prescriptions on recommendations of guideline for proper control of the disease. 
Guidelines aim to improve clinical practice but are not self-implementing. There is need to 
evaluate the doctors current medical practice and their knowledge on basis of guideline. 
1.1 Diabete mellitus 
Diabetes mellitus is a common chronic disorder characterized by chronic hyperglycemia 
together \\-ith other metabolic abnormalities (~RO 2003). It is due to insulin resistance or 
deficiency with increased hepatic glucose output (Alberti Zimmet 1998, Malaysian Diabetes 
mellitus Guideline, 2009). The effects of diabetes mellitus contain long-term damage, 
dysfunction and failure of various organs (Agrawal et al2011, Skyler 2004). The most common 
form of diabetes mellitus is type 2 diabetes. This disorder normally makes its appearance in older 
age (Grundy eta!., 2002). 
1.1 Cia sification of Diabetes Mellitus 
According to the WHO classification the diabetes mellitus and other categories of hyperglycemia 
are classified in to four types (WHO 2003, Dabelea et al., 2011). These four classes of diabetes 
ellitus include following classes: 
1.2.1 Type 1 DM 
Type 1 DM. al o known as in ulin-dcpendent diabetes, is a chronic condition in which the 
pancreas produces little or no insulin. a hormone needed to allow sugar (glucose) to enter cells to 
produce energy (WHO 2003, Ziegler Nepom 201 0). Its prevalence is 5-l 0% of diabetes cases 
( hulman D. 2010). Type I diabetes is a state in which destruction of pancreatic f3 cell takes 
place and usually resulted in absolute insulin deficiency in the body (Daneman 2006). Despite 
active research. type 1 diabetes has no cure, although it can be managed. 
1.2.2 Type 2 0~1 
Type 2 D:VL also kno"vn as adult-onset or noninsulin-dependent diabetes, is a chronic condition 
that affects the way by which body metabolizes sugar (glucose), the main source of energy in the 
body. Type 2 Dl\-1 is the most common type which is present more than 90% of patients of 
diabetes (\VHO 2003). It can affect in any age of the patient. Type 2 DM is developed with both 
genetic factors belongs to insulin secretion and environmental factors for example obesity, 
overeating. lack of exercise, and stress, as well as old age (Kohei, 201 0). 
1.2.3 Gestational OM 
Gestational diabetes mellitus (GDM) is condition of carbohydrate intolerance resulting in 
hyperglycemia of varying degrees of severity in pregnancy (Moore 2004). It has been reported 
that the incidence is about 1- 14 % of all pregnancies. It is usually take place in third trimester of 
pregnancy (Ismail et a!. , 2011 ). 
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1.2.4 Impaired gluco e tolerance {IGT) and impaired fa ting glucose (IFG) 
The IGT and IFG are also called as Pre-diabetes. Impaired glucose tolerance (IGT) and impaired 
fasting glycaemia (IFG) are middle conditions in between normality and diabetes (Saydah et al., 
2004). People with IGT or IFG are at high risk of developing type 2 diabetes, though it is not 
expected (Unwin eta/., 2002). 
1.3 Diabetic omplication 
Diabetes mellitus if not treated properly it can cause various complications in patients (Clinical 
Practice Guideline 2009). Diabetes and its complications make up a major public health problem 
all over the \\orld and are a main cause of morbidity and mortality (WHO 1999 Diabetes 2010 
www. diabete . org. uk1Documents1Reports/Diabete _in_the_UK_2010.). In actual fact, diabetes 
has reached epidemic proportions all over the world (Agrawal et a/., 2011). Uncontrolled 
diabetes is resulted in increased risk of microvascular and macrovascular complications (Nathan 
eta!. , 2009, Nazimek-Sie\\niak et al. . 2002). According to Clinical Practice Guideline 2009 the 
follo\\-ing five complications are considered as major complications of diabetes mellitus. 
1.3.1 Diabetic Retinopathy 
Diabetic retinopathy is developed as a result of damage to blood vessels of the retina in eyes 
(Kern 2007). The diabetic retinopathy is the leading cause in blindness in United States (Zhang 
eL a!. 20 10). The duration of diabetes is a main risk factor for diabetic retinopathy (Ruta et a/., 
20 13). In Type I OM the incidence of retinopathy in the fust 3-5 years is incredibly rare, but 20 
years over 90-95% of patients suffer from some degree of retinopathy (Chistiakov 2011). In 
2005 a Florida study by Chalam et al.. found from 25 to 80% of type 1 DM develop retinopathy 
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within 5 to 15 years after diagnosis (Chalam et a/ 2005). This rate is higher in patients of type 2 
DM and varie between patients who are taking insulin and not taking insulin. Moreover, 2007 
ational Diabetes tatistics of U reported that diabetes is the important reason of new cases of 
blindne s into adults having age 20 to 74 years in the US (Zhang et al2010). 
1.3.2 Diabetic europatby 
iabetic neuropathy is heterogeneous group of nerve damage conditions occurred due to 
uncontrolled DM (Daousi . 2010). It is the major ''microvascular" complications of diabetes. 
reuropathy is a common complication of both type 1 and type 2 diabetes. The prevalence of 
neuropathy is about 8% in nev.;ly diagnosed patients and more than 50% in patients with long 
duration of disease (Edwards et a/ .. 2008). However Vinik and Mahayana in 2004 reported that 
the true prevalence of diabetic neuropathy is not known. Different reports suggest that in 
any\\ here about 10 to 90% of diabetic patients suffering from diabetic neuropathy. but it truly 
depend on the criteria and method used to define neuropathy (Amato D. 2002). 
1.3.3 Diabetic epbropatby 
iabetic nephropathy is the most important cause of chronic kidney disease in patients with 
ncontrolled DM and is resulted in increased cardiovascular mortality (Gross et a/., 2005). 
rolonged elevation of blood sugar level will also affect the microvascular complication of 
idn y, thus interfering in its normal filtration function. This condition is called kidney disease 
f DM or diabetic nephropathy. The renal problem, whether associated to type 1 or 2 diabetes 
ellitus are similar (Kanwar et a/., 2008). Diabetic nephropathy can develop in both type 1 DM 
4 
and type 2 DM patients. About 40% patients of T2DM develop diabetic nephropathy (Gross et 
al .. 2005, Retnakaran eta/.. 2006). 
1.3.4 Diabetic Vasculopatby 
The complications related with diabetic vasculopathy are generally classified into two types: 
microvascular and macrovascular complications. In diabetes, macrovascular disease is the 
commonest source of mortality and morbidity and is responsible for high prevalence of vascular 
diseases for example stroke. myocardial infarction and peripheral vascular diseases.(Rahrnan et 
ol .. 2007) 
1.3.5 Cardiova cular Diseases 
Diabetes also has an effect on the heart muscle, resulting in both systolic and diastolic heart 
failure. The exact mechanism of this excess cardiovascular morbidity and mortality is still 
unkno~n (Dokken 2008). Cardiovascular disease (CVD) is the main reason of the morbidity and 
mortality when concerning with diabetes in the US. CVD is responsible for the majority of 
hospital admissions for diabetic patients and, together with kidney disease (Marks Raskin 2000) . 
.4 Diabetes and it major comorbidities according to CPG 2009 
omorbidity, described as the presence of other chronic conditions in the same person along 
ith an index-disease, occurs normally among patients with diabetes. The patient of diabetes 
often suffers from one or more comorbidities (Beckman Ja 2002). On the other hand, patients 
ith diabetes have both the diabetes related as well as non-diabetes related comorbidities. A lot 
of co morbidities are present with Diabetes mellitus. These co morbidities mainly contain the 
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1. 7.2 Com pari on between variou guidelines 
The compari on of only four guidelines (American. Australian. Canadian and Malaysian 
uideline ) are given as follows. the reason for selecting and discussing only four guidelines is 
the involvement of these four guidelines in making the final version of Malaysian Guideline 
2009 (Malaysian Clinical Practice Guideline 2009). 
ultural differences of various countries may results in the difference in recommendations of 
uidelines. The American and Canadian guidelines recommend that the diagnostic tests of 
diabete should be performed younger age or more frequently. The screening for community and 
creening for diabetic complications was not recommended by Canadian guidelines (Diabetes 
ssociation 1993 ). The Malaysian guideline recommends the screening of high risk population 
older than 35 years. The Malaysian guideline also recommends screening for pregnant women in 
ird trime ter. 
e guidelines are almost having same recommendations regarding the general management of 
diabetes mellitus in patients. These recommendations contains: diet control, exercise, weight 
management. life style modifications and preferred oral hypoglycemic agents (Nathan et al. , 
2009). The Metformin in widely recommended as drug of choice for overweight and obese 
patients (lnzucchi eta/., 20 12). The Malaysian guideline recommends the addition of second oral 
hypoglycemic agent when control of diabetes not obtained. Whereas the American and Canadian 
ide lines recommends addition in dose of the first oral hypoglycemic agent prescribed (Cramer 
et a! .. 2004 ). 
1 1 
The diagno tic te t and screening also differ in above mention four guidelines. The BMI values 
that indicate obesity ranges from 25-30 kg/m2 and target BP control also ranges from 130/80 to 
160/90 mmHg. llbAlc level also ranges from 6.5% to 7.0% in various guidelines. Also, the 
targets for control of lipid profile are different from various guidelines (Cramer et a!., 2004 ). 
The compari on of anous diagnosis and screenmg recommendations between American, 
Au tralian, Canadian and Malaysian Guidelines are given in the table 1.1 as follows. The reason 
{; r comparing only four guidelines is the popularity of these guidelines and involvement of 
certain recommendations of these guidelines in developing of Malaysian guideline (CPG 2009). 
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Table 1.1 Comparison between more popular guidelines 
~~ 
Guideline First year of Target for screening 
issued 
American 1995 Younger ages with higher risk. 
Guideline All adults with age 2::. 45 years. 
i 
Canadian 1998 : Screening for communities and diabetic 
Guideline complications are not recommended by 
Canadian guideline. 
Australian 1991 Ethnic groups with high prevalence aged 2::. 35 
Guideline years. 
People aged 2::. 45 years with one risk factor or 
more. 
Pregnant women aged 2::. 30 years 
People aged 2::. 55 years. 
Malaysian 1996 High risk population aged 2::. 35 years. 
Guideline Screening for pregnant women at 2::. 24/52 
period of gestation. 
FPG, Fasting Plasma Glucose, RPG, Random Plasma Glucose, 
OGTI, Oral Glucose Tolerance Test FBG, Fasting blood Glucose 
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Screening test Criteria for diagnosis of 
diabetes mellitus 
FPG or RPG FPG > 7.0 mmol/1 or 
casual PG > 11. 1 
FBG orOGTI' When FBG 2::. 7.0 mmol/1 
or OGTT 2::. 11.1 mmol/1 
FPG or 2-hours post When FPG 2::. 7.8 mmol/l 
load glucose during Or 
an OGTI RPG 2::. 11.1 mmol/1 
RBG or FBG When RBG 2::. 11 mmol/1 
confirm by FPG if result > 
7.8 mmol/1 confirm 
diabetes 
-
1.8 dherence to clinical practice guideline 
iteraturc revealed that the level of adherence of physician with guidelines and patients with 
their disea e is having direct relation \Vith control of disease. Non adherence to guideline is the 
main barrier in the control of diabetes mellitus in patients (Larme Pugh 2001, Seidu K.hunti 
20 12). Adherence of patients is very much important in control of disease. Without the 
cooperation of patients it is impossible to get control over diabetes mellitus (K.hattab et a! .. 
201 0). 
However, the physician can play a key role in control of diabetes mellitus. Thus adherence of 
physician is ver. much important in the control of diabetes mellitus. The adherence of physician 
directly affecting on the screening of disease and its complications and their treatments 
urthauer er al .. 2013). GenerallJ, in qualitative and in quantitative studies the hurdles to 
guideline-adherence have been evaluated widely regarding the physician's point of view. A 
systematic review of studies dealing with barriers of physician to guideline adherence. identified 
physicians· lack of awareness of a guidelines are the important causes of variation from 
recommended remedy (Cabana era!.. 1999). 
plementation of guideline· s recommendation is not a straight forward process. Different stages 
are included in its implementation. Pathman and his colleagues proposed a model that is known 
Awareness to Adherence Model to explain the stages resulted in adherence of guidelines 
1996). Pathman model is four phase model that is consist of awareness, 
reement, adoption and adherence. First of all awareness is necessary, then agree with it, then 
cide to follow it after that successfully practice it (Pathman eta!., 1996). 
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.9 Factors affecting guidelines adherence 
1.9.1 Doctor' knowledge on recommendations of guideline 
ctor·s adherence is directly related \\lith their knowledge on recommendations of 
guidelines(Ward et a!., 2002). \\hich is thought to be the first step in implementation of 
guidelines in their daily medical practice (Ellms 2006. K.hattab et al .. 2010. Weingarten eta!.. 
1995). Various studies show that the doctors having more knowledge about recommendations of 
guidelines resulted in batter clinical outcomes of the disease (De Belvis eta!.. 2009, Khan et al .. 
2010. atman et al .. 2012). 
However this relationship is not all the time present between doctors and their adherence \\lith 
guidelines. The doctor may have sufficient knowledge about recommendations of clinical 
ctice guideline but not implementing this knowledge in their daily medical practice (Al-
Habashneh eta!., 2010. Shaneyfelt et al .. 1999). 
1.9.2 Doctors attitude towards the recommendations of guidelines 
Doctor's attitude plays a key role in daily medical practice (Cabana et al.. 1999). Positive 
attitude towards the guideline may result in adherence on recommendations of guidelines (Shera 
et al .. 2002). The use of guideline can be predicted from attitude of doctors (Kortteisto et 
a/ .. 2010) which can be determined by various factors. such as their knowledge about guidelines. 
past clinical practice and outcomes of their practice (Clerc eta! .. 2011 ). 
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1.9.3 Doctors demographics 
Doctor's demographic characteristics are also having direct relationship in the adherence of 
clinical practice guidelines (Furthauer et a/., 2013 ). Generally the adherence of doctors increases 
in increasing the experience and designation of doctors. The increasing in the age and working 
e perience result in the better control of the disease (Al-Qazaz et a/ .. 2011 ). With the increase in 
the experience and designation of the doctors the adherence of the doctors towards clinical 
practice guideline will also increase. Doctors after increase in the designation became more 
conscious about the implementation of clinical practice guideline in their daily medical practice 
(Taba eta/ .. 2012). The main demographics are including in the current study is age, gender, 
e perience and designation. 
l.9A etting of practice characteri tic 
A cording to Cabanna et a/., 1999 not only kno'\vledge and attitude but also the implementation 
strategies. practice characteristics and audits of practice have affect on adherence of clinical 
practice guidelines. For example verbal and computer based reminders also have a positive effect 
on the implementation of guidelines. 
1.9.5 Affect of patients on adherence of disease 
t only doctors and system related factors but also patient factor is also important in adherence 
ofguiddines (Ahmad eta/., 2013. Klisiewicz Raal2009). Various studies reported the adherence 
of patients towards the di ease is also having direct relation in the control of the disease 
(R ichard eta/., 1993, Al-Qazaz et a/ ... 201 1, Valerio et a/., 2011, Bond eta/., 2012. Satman et 
a/.,; 20 12,). Experience and knowledge of diabetic patients regarding their medication play a 
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vital role in determining the achievement of adherence in their disease management (Al-Qazaz et 
a/ .. 20 I I). Knowledge and behaviors of patients are equally important in achieving adherence and 
ultimately diabetes mellitus control. Although patient knowledge is necessary for behavioral 
change. knowledge alone is not sufficient to stimulate the necessary behavioral changes expected 
of per ons with diabetes (Ardena et a/.,2010). 
1.10 Theoretical Frame work 
The above discussion about the non-adherence to\vards the guidelines and poor control of 
diabetes mellitus can be summed up in Fig 1.1 
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Literature show that the le el of adherence of physician with guidelines and patients with their 
dis ase is ha-.. ing direct relation with control of disease. on adherence to guideline is the main 
·er in the control of diabete mellitus in patients (Larme Pugh 2001, Seidu Khunti 2012). 
dherence of patients is very much important in control of disease. Without the cooperation of 
patients it is impossible to get control over diabetes mellitus (Khattab et al., 201 0). The 
adherence of phy ician is directly affecting on the screening of disease and its complications and 
their treatment (Furthauer et aL 2013). Various studies have been conducted in all over the 
orld to evaluate the adherence of doctor tov.ards the clinical practice guidelines. 
In table 2.1 various studie conducted in different countries on adherence of doctors are given. 
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Table 2.1 Different studies conducted in various countries to evaluate adherence of doctors on recommendation of guidelines 
Country Name of Researcher Total percentage of adherence Sample size Study Observation and Result 
&Year of seen Population 
Publication 
Jordan, Rola Al-Habashneh et al. Total 70% adherence of 164 Practicing This study assessed the Jordanian 
2010 practicing doctors was seen Doctors doctors ' knowledge of the 
toward guideline. connection between diabetes and 
oral health and assess their 
willingness to advise their 
diabetic patients to seek dental 
Treatment and determine the 
associated factors. 
Saudi Khan et al. The adherence of male 150 Physicians This study evaluates the 
Arabia, physicians toward the guideline knowledge, attitude and practice 
2011 was more (69%) as compared (KAP) of MOB Primary Care 
with the female physicians Physician on guideline provided 
(66%). by government of Saudi Arabia in 
the management of Type 2 
Diabetes Mellitus (OM). 
South Leslie KG et a!. Total theoretical adherence of 50 General A cross-sectional and descriptive 
Africa, general practitioners was 92% practitioners study was conducted. Although 
201 2 but actual adherence seen from (GPs) the GPs surveyed were aware of 
prescriptions was 60% towards the existence of guidelines for the 
guideline. assessment of patients with 
diabetes, their implementation 
was not satisfactory 
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untry Name of Researcher Total percentage of adherence Sample size Study Observation and Result 
car of seen Population 
1blication 
-
Malaysia, N. Ahmad et al. 67.1% adherence was seen in 26 doctors Doctors involve An overall fair level of 
2012 the doctors on recommendation and 650 in treatment of adherence with guideline and 
of guideline. patients. (25 II ypertension better control of hypertension 
per doctor) and established was observed. Guideline 
hypertension compliance practices resulted in 
patients. better control or hypertension. 
Malaysia, Ahmad et al. 73.5% adherence was seen in Prescriptions Doctors involve Prescribing practices were f'airly 
2012 doctors on recommendation of written by 13 in the treatment compliant with guidelines. 
clinical practice guideline. doctors for of Doctors poorly adhered to 
320 cardiovascular guidelines in hypertensive 
established diseases. patients with diabetes and LVI I. 
hypertensive Signi licantl y better hypertension 
patients with control was seen in patients who 
cardiovascular were on ACE inhibitors and 
diseases guidelines-adherent therapy. 
-
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The existing literature strongly recommends that different strategies can be used to measure the 
adherence of doctors to diabetes mellitus guidelines. These strategies mainly include~ 
I. Survey conducted by validated questionnaire 
II. Revision of medical record of patients 
IlL Diagnosis and current anti diabetic prescription pattern of prescribers 
2.1.1 Evaluation of guideline adherence with survey conducted by questionnaire 
The survey conducted by questionnaire is the most important method by which adherence of 
doctors with guideline can be determined (Baiardini eta!. , 2009, Retnak:aran et al .. 2006, Ward 
eta!. , 2002). The surveys have been used by various researchers to determine the familiarity of 
doctors with guidelines. By these studies different conclusions can be drawn. Basic salient 
features ofthese studies are shown in table 2.2 
21 
Table 2.2 Basic features of studies which have been evaluated guidelines adherence of doctors by survey conducted via 
questionnaires 
Study Evaluation of comorbidities Criteria to measure adherence Conclusion 
(Leslie Nkombua 2012) BP, Foot examination, No criteria was mention Although the GPs surveyed 
Eye examination were awaire of guidelines but 
their implementation was not 
satisfactory. 
(Shcra eta/., 2002) BP, Eye examination No criteria was mention Knowledge of family physicians 
need to improve & education 
programs are recommended. 
(Pcimani eta/.. 2010) No comorbidity was evaluated Yes. 50% cut-off Knowledge, attitude and practice 
criterion was used. of Physician were not suitable 
in treatment, control & 
complications of' DM. 
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(Khan eta!. , 201 0) 
GPs 
(Ratsep eta!., 2007) 
(Ward el a!., 2002) 
No comorbidity was evaluated 
No comorbidity was evaluated 
No comorbidity was evaluated 
BP, Blood Pressure; DM, Diabetes Mellitus; 
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No criteria was mention Ministry of Health appointed 
need to improve their knowledge 
attitude & practice in treating 
type 2 DM patients 
No criteria was mention Family doctors in Estonia 
Consider patient-related factors to 
be key issues in non-adherence to 
OM clinical practice guidelines. 
No criteria was mention Knowledge is only one of 
a spectrum or barriers that affects 
physician adherence to guidelines 
2.1.1 (a) Limitations for evaluation of guideline adherence with survey conducted by 
questionnaire 
I. The major limitation concerning with such studies is reliance on self reporting practice. 
which are predisposition; in which the respondents overestimation of their adherence 
with guideline. In a review study of only few studies show the actual adherence of the 
physicians with standard guidelines. Whereas the remaining studies show the theoretical 
adherence of physicians not actual implementation (De Belvis et al. , 2009, Ratsep et al., 
2006). 
II. None of the above mentioned study evaluated the actual practice of the physicians by 
actual prescriptions written by physicians. 
III. None of the above studies evaluated the physician·s knowledge on recommendations of 
diagnosis of DM and screenings of diabetic complications. 
2.1.2 Evaluation of guideline adherence with revision of medical records of patients 
(Retrospective studies) 
Reviewing of medical record of patients is another method by which the adherence of doctors or 
prescribers with guideline can be determined. In this type of study the prescriptions written by 
selected doctors taken from record than their adherence with guideline can be evaluated. 
Different studies have drawn different results regarding the adherence of doctors towards the 
recommendations of guidelines. Basic features of such type of studies are given in table 2.3. 
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